ATTCs call for action to assure the future of advance therapies adoption in the UK • ATTC Network – Advanced Therapy Treatment Centre
The future of access for patients to life changing advanced therapies lies in […]
Related Articles
Vivek Subbiah: The latest and greatest in cancer research in 2024 – OncoDaily
Vivek Subbiah: The latest and greatest in cancer research in 2024 / cancer, OncoDaily, Oncology, Vivek Subbiah
Auer rod–like inclusions in B-cell lymphoma mimicking therapy-related acute myeloid leukemia
Elena Frye Naharro, Michael A. Linden; Auer rod–like inclusions in B-cell lymphoma mimicking therapy-related acute myeloid leukemia. Blood 2024; 144 (26): 2793. doi: https://doi.org/10.1182/blood.2024025759 A…
The OncoAlert Newsletter is NOW OUT Click to Register
The OncoAlert Newsletter is now out for June 23-29, 2023
20 Big Cats Die From Bird Flu at a Washington Sanctuary (Gift Article)
More than half of the cats at the sanctuary in Shelton, Wash., died of the virus over the past several weeks.
The OncoAlert Newsletter is NOW OUT Click to Register
The OncoAlert Newsletter is now out for June 23-29, 2023
Use of the ESMO-Magnitude of Clinical Benefit Scale to guide HTA recommendations on coverage and reimbursement for cancer medicines: a retrospective analysis
Several factors informed HTA outcomes for new cancer medicines. A high ESMO-MCBS score, defined as indicating substantial clinical benefit, increased the likelihood of a positive…
Artificial intelligence-aided data mining of medical records for cancer detection and screening
The application of artificial intelligence methods to electronic patient records paves the way for large-scale analysis of multimodal data. Such population-wide data describing deep phenotypes…
All I want for Christmas is ethical, informative trials
Why the AQUILA trial is disappointing for patients and their loved ones
Tofacitinib versus Vedolizumab Among Bio-naïve Patients with Ulcerative Colitis: A Real-World Propensity-Weighted Comparison
AbstractBACKGROUND AND AIMS. Over the last decade, treatment options for moderate-to-severe ulcerative colitis (UC) have expanded. However, comparative stu
